Cargando…
Developments in administration of growth hormone treatment: focus on Norditropin(®) Flexpro(®)
Recombinant human growth hormone is used for the treatment of growth failure in children and metabolic dysfunction in adults with growth hormone deficiency. However, conventional growth hormone therapy requires daily subcutaneous injections that may affect treatment adherence, and subsequently effic...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063658/ https://www.ncbi.nlm.nih.gov/pubmed/21448295 http://dx.doi.org/10.2147/PPA.S10985 |